Tech IP counsel wary of overreaching Amgen v Sanofi ruling In-house tech sources say Amgen v Sanofi has the potential to stifle their prosecution and litigation strategies if SCOTUS’s decision is too broad... View Full Article Related Articles News Feed Roundup Ready 2 Patent Litigation Bayer CropScience v. Pierce, et al. (E.D. Mo 2023) Bayer and its subsidiary Monsanto have filed a new set of… Learn More News Feed This week on MIP: DABUS appeal, ‘secret’ commissions We provide a rundown of Managing IP’s news and analysis coverage from the week, and review what’s been happening elsewhere… Learn More News Feed AI and Inventorship – USPTO Request for Comments Learn More
